U.S. Online Retail and Ecommerce Stock News

KLA (KLAC) just got a confidence boost after Jefferies tagged it as a top pick for 2026, following earnings that topped expectations and sparked a wave of more upbeat analyst views. See our latest analysis for KLA. That call from Jefferies comes on top of a powerful run, with a roughly 13.5% 1 month share price return feeding into a near doubling of the year to date share price and a massive five year total shareholder return above 400%. This suggests momentum is still very much on KLA’s...

In recent days, Vericel reported higher fiscal Q3 2025 revenue and reaffirmed its full-year revenue and profitability guidance, highlighting expected growth in its MACI product line alongside stable gross and adjusted EBITDA margins. At the same time, multiple research firms, including Truist Securities and Canaccord Genuity, reiterated positive ratings on Vericel, signaling continued institutional confidence despite higher operating expenses tied to headcount growth and new manufacturing...

OGE Energy (OGE) has quietly slipped about 4% over the past month and roughly 5% in the past 3 months, even as its one year total return still sits near 7%. See our latest analysis for OGE Energy. At around $42.50 per share, OGE’s recent pullback reflects cooling short term sentiment even as its one year total shareholder return of about 7% and five year total shareholder return near 69% point to steadier, long term momentum. If OGE’s slower moving utility profile has you wondering what else...

Surf Air Mobility (SRFM) is back on traders radar after Q3 results topped its own revenue guidance, and management raised the full year outlook while also unveiling a Palantir partnership that includes a sector specific exclusivity agreement. See our latest analysis for Surf Air Mobility. Even with the Palantir deal and stronger Q3 narrative giving the story fresh energy, Surf Air Mobility’s share price at $1.83 still reflects a bruising year. A sharp 90 day share price return of minus 58.97...

In recent days, Wells Fargo’s Benjamin Burnett reaffirmed a Buy rating on Liquidia Technologies, aligning with a broader analyst consensus of Strong Buy and reflecting confidence following the company’s latest quarterly update. Liquidia’s strong year-over-year revenue growth has reinforced perceptions that the company is building operational momentum, which may be influencing how analysts and investors frame its long-term potential. We will now examine how the reaffirmed Buy rating,...

FirstEnergy (FE) is back in the spotlight after agreeing to a roughly $276 million settlement tied to the House Bill 6 scandal, a deal that could finally clear major regulatory overhangs for investors. See our latest analysis for FirstEnergy. The settlement headlines land after a choppy few months, with a roughly 5.7% 1 month share price return decline, but a still solid double digit year to date share price gain and a roughly 84% 5 year total shareholder return suggesting that longer term...

In recent days, Blue Bird reported robust quarterly results with higher revenue and net profit, alongside long-term sales growth and expanding margins that have supported renewed investor optimism. Analysts have responded with stronger positive ratings and outlooks, citing the company’s leadership in alternative-power school buses, a rebounding backlog, and improved operational efficiency. We’ll now examine how this improving analyst sentiment, supported by better margins and cash flow,...

Centuri Holdings (CTRI) just lined up nearly $500 million in fresh customer awards, mostly new work, and that kind of contract momentum is exactly what catches investors’ attention in an infrastructure name. See our latest analysis for Centuri Holdings. That contract win lands on top of a powerful run, with a roughly 33% 1 month share price return and about 36% year to date share price return signaling building momentum rather than a one day pop. If Centuri’s move has you rethinking where the...

Earlier in December, Affirm Holdings renewed its buy-now-pay-later agreement with Amazon through January 2031 and expanded partnerships with Shopify in the U.K. and REVOLVE across Canada and the U.K., while management reported healthy holiday-quarter demand and stable delinquency trends. By publicly challenging third-party data pointing to weaker volumes and reiterating confidence in its credit performance, Affirm addressed key investor worries about the durability of its growth and risk...

On 10 December 2025, DoubleVerify announced that its DV Authentic Attention product is now integrated with TikTok as the first badged TikTok Marketing Partner solution for attention measurement, providing advertisers with direct, impression-level signals on exposure and engagement across formats, creatives and objectives. This move deepens DoubleVerify’s role inside a major social platform, giving advertisers new tools to diagnose creative fatigue, benchmark TikTok performance, and shift...

Omnicell (OMCL) just rolled out Titan XT, a new enterprise level automated dispensing system built on its OmniSphere cloud platform, and the launch is already reshaping how investors think about the stock. See our latest analysis for Omnicell. The launch of Titan XT coincides with Omnicell’s 30 day share price return of 30.11 percent and 90 day share price return of 51.10 percent, which signal rapidly building momentum. However, the 5 year total shareholder return of negative 60.02 percent...

ABM Industries (ABM) slid after its latest earnings update, as a headline miss on expectations and cautious commentary on margins and the WGNSTAR acquisition overshadowed decent revenue growth and a fresh dividend increase. See our latest analysis for ABM Industries. The latest pullback, including a 1 day share price return of minus 2.99% and year to date share price return of minus 17.51%, suggests sentiment has cooled despite solid earnings recovery, dividend growth and ongoing buybacks...

Hecla Mining recently hit a new 52-week high after reporting record Q3 2025 revenue, earnings, and cash flow, supported by very large year-to-date silver price gains and reduced leverage. The company’s addition to the S&P MidCap 400 Index and progress on projects such as Polaris and Midas highlight growing operational scale and exploration depth that could reshape how investors view its silver-focused portfolio. We’ll now examine how Hecla’s record earnings and S&P MidCap 400 inclusion may...

On December 18, 2025, VeriSign’s Executive Chairman, President, and CEO D Bidzos sold 9,000 company shares, contributing to a year of substantial insider selling highlighted in recent SEC filings. These transactions, set against VeriSign’s role in operating critical internet infrastructure, draw attention to how leadership’s trading activity aligns with its long-term outlook on the core domain registry business. We’ll now explore how this pattern of insider selling, particularly by the CEO,...

Cintas Corporation ( NASDAQ:CTAS ) came out with its second-quarter results last week, and we wanted to see how the...

Earlier this month, Talen Energy reshaped its leadership structure by appointing former CFO Terry L. Nutt as President and naming Cole Muller as Chief Financial Officer, alongside a series of senior operational and development role changes to support its evolving power and infrastructure business. The extensive reallocation of responsibilities, from nuclear oversight and fleet operations to new generation asset development and data center strategy, signals a concerted push to align...

Etsy, Inc. recently announced a new US$750 million share repurchase authorization, lifting its total approved buyback capacity to nearly US$1 billion and confirming Fred Wilson will become Lead Independent Director in January 2026 alongside a planned CEO transition. The combination of substantial buybacks and enhanced board oversight highlights Etsy’s emphasis on capital return and governance as it confronts slowing gross merchandise sales and buyer engagement. Now we’ll examine how Etsy’s...

Earlier this month, Citizens Financial Group reported that analysts expect its fiscal fourth-quarter 2025 diluted EPS to reach US$1.12, implying a very large year-over-year profit increase, after the bank topped Wall Street earnings estimates in each of the previous four quarters. The bank’s performance has been underpinned by expansion in its private bank and wealth franchise, strong capital markets activity, and tighter cost control supported by technology and private banking investments...

Earlier this year, Regencell Bioscience Holdings disclosed that the US Department of Justice had launched an investigation into trading of its shares and requested extensive operational, financial and accounting records, prompting the company to warn of potentially significant legal costs and penalties. The subsequent involvement of law firm Bronstein, Gewirtz & Grossman, LLC, which is examining potential claims on behalf of Regencell purchasers, adds another layer of legal uncertainty...

In recent days, Procter & Gamble’s Pantene brand expanded its influencer push by launching a limited‑edition “As seen in Alix’s Shower” Abundant & Strong kit with creator Alix Earle, while the company also confirmed the planned 2026 retirement of long‑time Health Care CEO Jennifer Davis. Together with prior announcements on European logistics expansion and portfolio pruning, these moves highlight how P&G is refining its brand reach while tightening its operational footprint. We’ll now...

Vera Therapeutics (VERA) has been on investors’ radar after upbeat analyst reports flagged two key drivers: rising revenue expectations for kidney drug candidate atacicept and a cash boost from a recent follow on equity raise. See our latest analysis for Vera Therapeutics. The upbeat story around atacicept and the recent equity raise is already showing up in the tape, with a roughly 80 percent 1 month share price return and a near doubling over three months. This builds on a strong 3 year...

Innoviva, Inc. recently received US FDA approval for NUZOLVENCE (zoliflodacin), a first-in-class, single-dose oral antibiotic to treat uncomplicated urogenital gonorrhea in adults and pediatric patients. This marks one of the first new FDA-approved treatments for gonorrhea in nearly twenty years, underscoring Innoviva’s role in addressing antibiotic resistance and unmet infectious disease needs. We’ll now explore how bringing a first-in-class, single-dose oral treatment for gonorrhea affects...

Core & Main (CNM) just checked several key boxes in its latest earnings update, pairing steady third quarter growth with a clear commitment to acquisitions, share buybacks and disciplined capital allocation. See our latest analysis for Core & Main. The stock has cooled slightly after the earnings pop, with a 1 month share price return of 18.01% and a 3 year total shareholder return of 181.16%. This suggests momentum is still firmly on Core & Main’s side. If this kind of steady execution...

Kinder Morgan (KMI) just tightened the picture for income investors, issuing fresh 2025 and 2026 profit guidance alongside plans for a higher 2026 dividend that extends its long running payout growth streak. See our latest analysis for Kinder Morgan. At a recent share price of $26.49, Kinder Morgan’s year to date share price return of minus 5.76 percent contrasts with its 5 year total shareholder return of 159.74 percent. This suggests that longer term income focused momentum remains firmly...